loading page

New Pediatric Leukemia and Lymphoma Diagnoses During the Coronavirus-2019 Pandemic, a New York Perspective
  • +3
  • Layne Silver,
  • Pooja Desai,
  • Sareen Shah,
  • Julie Krystal,
  • Matthew Taylor,
  • Kristina Murphy
Layne Silver
Cohen Children's Medical Center

Corresponding Author:[email protected]

Author Profile
Pooja Desai
Cohen Children's Medical Center
Author Profile
Sareen Shah
Cohen Children's Medical Center
Author Profile
Julie Krystal
Cohen Children's Medical Center
Author Profile
Matthew Taylor
Cohen Children's Medical Center
Author Profile
Kristina Murphy
Cohen Children's Medical Center
Author Profile

Abstract

Viral infections and seasonality are linked with trends in new pediatric leukemia and lymphoma cases. The COVID-19 pandemic disrupted this norm, and subsequently the international medical community observed a decrease in new diagnoses of hematologic cancers in children. However, this was not the trend observed at Cohen Children's Medical Center where, despite examining fifteen months during the COVID-19 pandemic, we did not see a statistically significant decrease in monthly cases. Rather, cases remained constant as compared to pre-COVID-19 periods. This warrants further study at a multi-institutional level to investigate the association between COVID-19 and rates of pediatric leukemia and lymphoma.